Researchers from McMaster University’s Department of Medicine, presenting at this year’s American Society for Bone and Mineral Research’s annual meeting, found that the magnitude of the effect of SSRIs on the risk of bone fractures is greater than previously thought. “We do a lot to prevent glucocorticoid fractures, but this study showed that SSRIs seem to have as great an association with fractures as glucocorticoids and in fact have a slightly greater effect,” said the lead author. “This is important because we have a lot of guidelines advising us on what to do about glucocorticoid-induced osteoporosis, but we don’t have any on SSRI-induced osteoporosis.”
Link to medscape article requires log-in / account on Medscape.
Report comment